{"id":2975,"date":"2024-06-10T12:49:42","date_gmt":"2024-06-10T10:49:42","guid":{"rendered":"https:\/\/glycanostics.com\/?p=2975"},"modified":"2024-07-19T13:17:04","modified_gmt":"2024-07-19T11:17:04","slug":"v-ta3-sme-diskutovali-o-nakladoch-spojenych-s-liecbou-rakoviny","status":"publish","type":"post","link":"https:\/\/glycanostics.com\/sk\/v-ta3-sme-diskutovali-o-nakladoch-spojenych-s-liecbou-rakoviny\/","title":{"rendered":"Diskusia v TA3 o n\u00e1kladoch spojen\u00fdch s lie\u010dbou rakoviny"},"content":{"rendered":"

Prijali sme pozvanie slovenskej telev\u00edzie TA3, aby sme diskutovali o rakovine prostaty, ktor\u00e1 patr\u00ed u\u00a0mu\u017eov k\u00a0naj\u010dastej\u0161\u00edm onkologick\u00fdm ochoreniam na Slovensku.<\/p>\n

MUDr. Boris Koll\u00e1rik, k\u013e\u00fa\u010dov\u00fd odborn\u00edk Ministerstva zdravotn\u00edctva SR v oblasti urol\u00f3gie, predstavil jej v\u00fdskyt, s\u00fa\u010dasn\u00e9 diagnostick\u00e9 a terapeutick\u00e9 met\u00f3dy, ako aj skr\u00edningov\u00fd program, ktor\u00fd sa na Slovensku \u010doskoro spust\u00ed. Na\u0161a gener\u00e1lna riadite\u013eka Eva Kov\u00e1\u010dov\u00e1 FCCA predstavila aj nov\u00fd test na b\u00e1ze krvi vyvinut\u00fd spolo\u010dnos\u0165ou Glycanostics – Giasay\u00ae Test<\/a> na rakovinu prostaty, ktor\u00fd je u\u017e dostupn\u00fd pre pacientov na Slovensku a poskytuje najpresnej\u0161ie v\u00fdsledky zo v\u0161etk\u00fdch v s\u00fa\u010dasnosti dostupn\u00fdch testov. Sl\u00fa\u017ei ako test druh\u00e9ho n\u00e1zoru, ktor\u00fd pacientom a ich urol\u00f3gom poskytne \u010fal\u0161ie inform\u00e1cie e\u0161te pred vy\u0161etren\u00edm magnetickou rezonanciou alebo biopsiou prostaty.<\/p>\n

Podelili sme sa aj o skvel\u00e9 spr\u00e1vy s\u00favisiace s prebiehaj\u00facim procesom certifik\u00e1cie zna\u010dky CE a pl\u00e1nmi na uvedenie n\u00e1\u0161ho testu prostredn\u00edctvom siet\u00ed laborat\u00f3ri\u00ed na Slovensku, v Rak\u00fasku a Nemecku u\u017e v roku 2025.<\/p>\n

N\u00e1klady na rakovinu s\u00fa skoro dvojn\u00e1sobn\u00e9 | ta3<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Prijali sme pozvanie slovenskej telev\u00edzie TA3, aby sme diskutovali o rakovine prostaty, ktor\u00e1 patr\u00ed u\u00a0mu\u017eov k\u00a0naj\u010dastej\u0161\u00edm onkologick\u00fdm ochoreniam na Slovensku. MUDr. Boris Koll\u00e1rik, k\u013e\u00fa\u010dov\u00fd odborn\u00edk Ministerstva zdravotn\u00edctva SR v oblasti urol\u00f3gie, predstavil jej v\u00fdskyt, s\u00fa\u010dasn\u00e9 diagnostick\u00e9 a terapeutick\u00e9 met\u00f3dy, ako aj skr\u00edningov\u00fd program, ktor\u00fd sa na Slovensku \u010doskoro spust\u00ed. Na\u0161a gener\u00e1lna riadite\u013eka Eva Kov\u00e1\u010dov\u00e1 FCCA […]<\/p>\n","protected":false},"author":5,"featured_media":2973,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_mi_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[23],"tags":[],"yoast_head":"\nDiskusia v TA3 o n\u00e1kladoch spojen\u00fdch s lie\u010dbou rakoviny - Glycanostics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/glycanostics.com\/sk\/v-ta3-sme-diskutovali-o-nakladoch-spojenych-s-liecbou-rakoviny\/\" \/>\n<meta property=\"og:locale\" content=\"sk_SK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Diskusia v TA3 o n\u00e1kladoch spojen\u00fdch s lie\u010dbou rakoviny - Glycanostics\" \/>\n<meta property=\"og:description\" content=\"Prijali sme pozvanie slovenskej telev\u00edzie TA3, aby sme diskutovali o rakovine prostaty, ktor\u00e1 patr\u00ed u\u00a0mu\u017eov k\u00a0naj\u010dastej\u0161\u00edm onkologick\u00fdm ochoreniam na Slovensku. MUDr. Boris Koll\u00e1rik, k\u013e\u00fa\u010dov\u00fd odborn\u00edk Ministerstva zdravotn\u00edctva SR v oblasti urol\u00f3gie, predstavil jej v\u00fdskyt, s\u00fa\u010dasn\u00e9 diagnostick\u00e9 a terapeutick\u00e9 met\u00f3dy, ako aj skr\u00edningov\u00fd program, ktor\u00fd sa na Slovensku \u010doskoro spust\u00ed. Na\u0161a gener\u00e1lna riadite\u013eka Eva Kov\u00e1\u010dov\u00e1 FCCA […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/glycanostics.com\/sk\/v-ta3-sme-diskutovali-o-nakladoch-spojenych-s-liecbou-rakoviny\/\" \/>\n<meta property=\"og:site_name\" content=\"Glycanostics\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-10T10:49:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-19T11:17:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/glycanostics.com\/wp-content\/uploads\/2024\/07\/2024_06_TA3.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Miloslava Lakostikova\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Autor\" \/>\n\t<meta name=\"twitter:data1\" content=\"Miloslava Lakostikova\" \/>\n\t<meta name=\"twitter:label2\" content=\"Predpokladan\u00fd \u010das \u010d\u00edtania\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 min\u00fata\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/glycanostics.com\/sk\/v-ta3-sme-diskutovali-o-nakladoch-spojenych-s-liecbou-rakoviny\/\",\"url\":\"https:\/\/glycanostics.com\/sk\/v-ta3-sme-diskutovali-o-nakladoch-spojenych-s-liecbou-rakoviny\/\",\"name\":\"Diskusia v TA3 o n\u00e1kladoch spojen\u00fdch s lie\u010dbou rakoviny - Glycanostics\",\"isPartOf\":{\"@id\":\"https:\/\/glycanostics.com\/#website\"},\"datePublished\":\"2024-06-10T10:49:42+00:00\",\"dateModified\":\"2024-07-19T11:17:04+00:00\",\"author\":{\"@id\":\"https:\/\/glycanostics.com\/#\/schema\/person\/c5a370067e4556b810ab266691d3b5c9\"},\"breadcrumb\":{\"@id\":\"https:\/\/glycanostics.com\/sk\/v-ta3-sme-diskutovali-o-nakladoch-spojenych-s-liecbou-rakoviny\/#breadcrumb\"},\"inLanguage\":\"sk-SK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/glycanostics.com\/sk\/v-ta3-sme-diskutovali-o-nakladoch-spojenych-s-liecbou-rakoviny\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/glycanostics.com\/sk\/v-ta3-sme-diskutovali-o-nakladoch-spojenych-s-liecbou-rakoviny\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/glycanostics.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Diskusia v TA3 o n\u00e1kladoch spojen\u00fdch s lie\u010dbou rakoviny\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/glycanostics.com\/#website\",\"url\":\"https:\/\/glycanostics.com\/\",\"name\":\"Glycanostics\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/glycanostics.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"sk-SK\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/glycanostics.com\/#\/schema\/person\/c5a370067e4556b810ab266691d3b5c9\",\"name\":\"Miloslava Lakostikova\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sk-SK\",\"@id\":\"https:\/\/glycanostics.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c0f22bfd607fbb763d8c1246fd9f446d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c0f22bfd607fbb763d8c1246fd9f446d?s=96&d=mm&r=g\",\"caption\":\"Miloslava Lakostikova\"},\"url\":\"https:\/\/glycanostics.com\/sk\/author\/miloslava-lakostikova\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Diskusia v TA3 o n\u00e1kladoch spojen\u00fdch s lie\u010dbou rakoviny - Glycanostics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/glycanostics.com\/sk\/v-ta3-sme-diskutovali-o-nakladoch-spojenych-s-liecbou-rakoviny\/","og_locale":"sk_SK","og_type":"article","og_title":"Diskusia v TA3 o n\u00e1kladoch spojen\u00fdch s lie\u010dbou rakoviny - Glycanostics","og_description":"Prijali sme pozvanie slovenskej telev\u00edzie TA3, aby sme diskutovali o rakovine prostaty, ktor\u00e1 patr\u00ed u\u00a0mu\u017eov k\u00a0naj\u010dastej\u0161\u00edm onkologick\u00fdm ochoreniam na Slovensku. MUDr. Boris Koll\u00e1rik, k\u013e\u00fa\u010dov\u00fd odborn\u00edk Ministerstva zdravotn\u00edctva SR v oblasti urol\u00f3gie, predstavil jej v\u00fdskyt, s\u00fa\u010dasn\u00e9 diagnostick\u00e9 a terapeutick\u00e9 met\u00f3dy, ako aj skr\u00edningov\u00fd program, ktor\u00fd sa na Slovensku \u010doskoro spust\u00ed. Na\u0161a gener\u00e1lna riadite\u013eka Eva Kov\u00e1\u010dov\u00e1 FCCA […]","og_url":"https:\/\/glycanostics.com\/sk\/v-ta3-sme-diskutovali-o-nakladoch-spojenych-s-liecbou-rakoviny\/","og_site_name":"Glycanostics","article_published_time":"2024-06-10T10:49:42+00:00","article_modified_time":"2024-07-19T11:17:04+00:00","og_image":[{"width":1280,"height":720,"url":"https:\/\/glycanostics.com\/wp-content\/uploads\/2024\/07\/2024_06_TA3.jpg","type":"image\/jpeg"}],"author":"Miloslava Lakostikova","twitter_card":"summary_large_image","twitter_misc":{"Autor":"Miloslava Lakostikova","Predpokladan\u00fd \u010das \u010d\u00edtania":"1 min\u00fata"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/glycanostics.com\/sk\/v-ta3-sme-diskutovali-o-nakladoch-spojenych-s-liecbou-rakoviny\/","url":"https:\/\/glycanostics.com\/sk\/v-ta3-sme-diskutovali-o-nakladoch-spojenych-s-liecbou-rakoviny\/","name":"Diskusia v TA3 o n\u00e1kladoch spojen\u00fdch s lie\u010dbou rakoviny - Glycanostics","isPartOf":{"@id":"https:\/\/glycanostics.com\/#website"},"datePublished":"2024-06-10T10:49:42+00:00","dateModified":"2024-07-19T11:17:04+00:00","author":{"@id":"https:\/\/glycanostics.com\/#\/schema\/person\/c5a370067e4556b810ab266691d3b5c9"},"breadcrumb":{"@id":"https:\/\/glycanostics.com\/sk\/v-ta3-sme-diskutovali-o-nakladoch-spojenych-s-liecbou-rakoviny\/#breadcrumb"},"inLanguage":"sk-SK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/glycanostics.com\/sk\/v-ta3-sme-diskutovali-o-nakladoch-spojenych-s-liecbou-rakoviny\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/glycanostics.com\/sk\/v-ta3-sme-diskutovali-o-nakladoch-spojenych-s-liecbou-rakoviny\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/glycanostics.com\/"},{"@type":"ListItem","position":2,"name":"Diskusia v TA3 o n\u00e1kladoch spojen\u00fdch s lie\u010dbou rakoviny"}]},{"@type":"WebSite","@id":"https:\/\/glycanostics.com\/#website","url":"https:\/\/glycanostics.com\/","name":"Glycanostics","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/glycanostics.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"sk-SK"},{"@type":"Person","@id":"https:\/\/glycanostics.com\/#\/schema\/person\/c5a370067e4556b810ab266691d3b5c9","name":"Miloslava Lakostikova","image":{"@type":"ImageObject","inLanguage":"sk-SK","@id":"https:\/\/glycanostics.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/c0f22bfd607fbb763d8c1246fd9f446d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c0f22bfd607fbb763d8c1246fd9f446d?s=96&d=mm&r=g","caption":"Miloslava Lakostikova"},"url":"https:\/\/glycanostics.com\/sk\/author\/miloslava-lakostikova\/"}]}},"_links":{"self":[{"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/posts\/2975"}],"collection":[{"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/comments?post=2975"}],"version-history":[{"count":2,"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/posts\/2975\/revisions"}],"predecessor-version":[{"id":2989,"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/posts\/2975\/revisions\/2989"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/media\/2973"}],"wp:attachment":[{"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/media?parent=2975"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/categories?post=2975"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/tags?post=2975"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}